Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Canadian Journal of Microbiology|August 1, 1991
Serotypes and subtypes of Neisseria meningitidis serogroup B strains associated with meningococcal disease in Canada, 1977-1989F E Ashton, L Mancino, A J Ryan, et al.
The Journal of Infectious Diseases|March 1, 1994
Phenotypic and genotypic changes in a new clone complex of Neisseria meningitidis causing disease in The Netherlands, 1958-1990R J Scholten, J T Poolman, H A Valkenburg, et al.
Infection and Immunity|January 1, 1993
Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvantsA F Verheul, J A Van Gaans, E J Wiertz, et al.
Infection and Immunity|November 1, 1992
Antibodies to meningococcal class 1 outer membrane proteins in South African complement-deficient and complement-sufficient subjectsA Orren, R E Warren, P C Potter, et al.
Infection and Immunity|October 1, 1988
Electromorphic characterization and description of conserved epitopes of the lipooligosaccharides of group A Neisseria meningitidisJ J Kim, R E Mandrell, Z Hu, et al.
Infection and Immunity|December 1, 1992
Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of ChinaJ F Wang, D A Caugant, X Li, et al.
Infection and Immunity|March 1, 1991
Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugatesA F Verheul, A K Braat, J M Leenhouts, et al.
Infection and Immunity|October 1, 1991
Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccinesC C Peeters, A M Tenbergen-Meekes, J T Poolman, et al.
The Tokai Journal of Experimental and Clinical Medicine|January 1, 1988
Biochemical properties of pertussis toxinD L Burns, S Z Hausman, M H Witvliet, et al.
Methods in Molecular Medicine|March 2, 2011
Polysaccharicb-conjugate vaccinesC C Peeters, P R Lagerman, O de Weers, et al.
Pageof 10